Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1300613.RAv8Tj_1Xj2rAGoHR1t6-t_zk-InZWPSn8hd2_RYTVKn4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1300613.RAv8Tj_1Xj2rAGoHR1t6-t_zk-InZWPSn8hd2_RYTVKn4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1300613.RAv8Tj_1Xj2rAGoHR1t6-t_zk-InZWPSn8hd2_RYTVKn4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1300613.RAv8Tj_1Xj2rAGoHR1t6-t_zk-InZWPSn8hd2_RYTVKn4130_provenance.
- NP1300613.RAv8Tj_1Xj2rAGoHR1t6-t_zk-InZWPSn8hd2_RYTVKn4130_assertion description "[In most cases of CML and some cases of Ph+ ALL the protooncogene ABL from 9q34 is translocated to the breakpoint cluster region (bcr) of the BCR gene at 22q11 to form a chimeric gene encoding a novel 210-kd protein (P210 BCR-ABL) with enhanced tyrosine kinase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1300613.RAv8Tj_1Xj2rAGoHR1t6-t_zk-InZWPSn8hd2_RYTVKn4130_provenance.
- NP1300613.RAv8Tj_1Xj2rAGoHR1t6-t_zk-InZWPSn8hd2_RYTVKn4130_assertion evidence source_evidence_literature NP1300613.RAv8Tj_1Xj2rAGoHR1t6-t_zk-InZWPSn8hd2_RYTVKn4130_provenance.
- NP1300613.RAv8Tj_1Xj2rAGoHR1t6-t_zk-InZWPSn8hd2_RYTVKn4130_assertion SIO_000772 3179449 NP1300613.RAv8Tj_1Xj2rAGoHR1t6-t_zk-InZWPSn8hd2_RYTVKn4130_provenance.
- NP1300613.RAv8Tj_1Xj2rAGoHR1t6-t_zk-InZWPSn8hd2_RYTVKn4130_assertion wasDerivedFrom befree-2016 NP1300613.RAv8Tj_1Xj2rAGoHR1t6-t_zk-InZWPSn8hd2_RYTVKn4130_provenance.
- NP1300613.RAv8Tj_1Xj2rAGoHR1t6-t_zk-InZWPSn8hd2_RYTVKn4130_assertion wasGeneratedBy ECO_0000203 NP1300613.RAv8Tj_1Xj2rAGoHR1t6-t_zk-InZWPSn8hd2_RYTVKn4130_provenance.
- befree-2016 importedOn "2016-02-19" NP1300613.RAv8Tj_1Xj2rAGoHR1t6-t_zk-InZWPSn8hd2_RYTVKn4130_provenance.